BSUM on stage at HealthBIO 2026 and the Drug Discovery & Lead Optimization conference

In September 2026 BSUM founder Juhani Lahdenperä delivered the Annual Review: Biotech Year 2025–2026 at HealthBIO 2026 in Turku, Finland's leading life science conference, now in its 20th year, together with Tom Palenius of Innocelex | Biocelex Oy.

He was also confirmed as a keynote speaker at the 10th International Conference on Drug Discovery & Lead Optimization, 7–9 October 2026 in the San Francisco Bay Area. The talk, "AI Approaches to Maintain Deal Making Capabilities of a Life Science Company: An Operational Case Study", draws on BSUM's own AI-assisted due diligence work.

Both talks share the theme behind BSUM's work: keeping life-science deals moving with rigorous, fast analysis, without giving up control of confidential data.